Cover Page - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Apr. 21, 2023 |
Jun. 30, 2022 |
|
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Document Period End Date | Dec. 31, 2022 | ||
| Document Fiscal Year Focus | 2022 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Interactive Data Current | Yes | ||
| Trading Symbol | FBRX | ||
| Entity Current Reporting Status | Yes | ||
| Entity Registrant Name | FORTE BIOSCIENCES, INC. | ||
| Entity Central Index Key | 0001419041 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Shell Company | false | ||
| ICFR Auditor Attestation Flag | false | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Title of 12(b) Security | Common Stock | ||
| Security Exchange Name | NASDAQ | ||
| Entity File Number | 001-38052 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Tax Identification Number | 26-1243872 | ||
| Entity Address, Address Line One | 3060 Pegasus Park Drive, Building 6 | ||
| Entity Address, City or Town | Dallas | ||
| Entity Address, State or Province | TX | ||
| Entity Address, Postal Zip Code | 75247 | ||
| City Area Code | 310 | ||
| Local Phone Number | 618-6994 | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Entity Public Float | $ 17.5 | ||
| Entity Common Stock, Shares Outstanding | 21,007,069 | ||
| Documents Incorporated by Reference [Text Block] | None. | ||
| Amendment Description | This Amendment No. 1 on Form 10-K/A (this ”Amendment”) to the Annual Report on Form 10-K of Forte Biosciences, Inc., a Delaware corporation (referred to as “FBRX,” the “Company,” “we,” “us,” or “our”) for the fiscal year ended December 31, 2022, originally filed with the Securities and Exchange Commission (SEC) on March 31, 2023 (the “Original Filing”), is being filed for the purpose of including the information required by Part III of Form 10-K. This information was previously omitted from the Original Filing in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to be incorporated in the Form 10-K by reference from our definitive proxy statement if such proxy statement is filed no later than 120 days after our fiscal year-end. The reference on the cover page of the Original Filing to the incorporation by reference to portions of our definitive proxy statement into Part III of the Original Filing has been deleted. This Amendment No. 1 hereby amends and restates in their entirety the cover page and Items 10 through 14 of Part III of the Original Filing. As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, in connection with this Amendment, our Chief Executive Officer and Chief Financial Officer are providing Rule 13a-14(a) certifications as included herein. We are amending Item 15 of Part IV solely to reflect the inclusion of these certifications. Since no new financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted. Similarly, since no financial statements have been included in this Amendment, certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 have been omitted. Except as described above, this Amendment does not modify or update disclosure in, or exhibits to, the Original Filing. Furthermore, this Amendment does not change any previously reported financial results, nor does it reflect events occurring after the filing date of the Original Filing. Information not affected by this Amendment remains unchanged and reflects the disclosures made at the time the Original Filing was filed. All statements in this Amendment that are not historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements can generally be identified as such because the context of the statement will include words such as “may,” “will,” “intend,” “plans,” “believes,” “anticipates,” “expects,” “estimates,” “predicts,” “potential,” “continue,” “opportunity,” “goals,” or “should,” the negative of these words or words of similar import. Similarly, statements that describe our future plans, strategies, intentions, expectations, objectives, goals or prospects are also forward-looking statements. These forward-looking statements are or will be, as applicable, based largely on our expectations and projections about future events and future trends affecting our business, and so are or will be, as applicable, subject to risks and uncertainties including but not limited to the risk factors discussed in the Original Filing, that could cause actual results to differ materially from those anticipated in the forward-looking statements. We caution investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements. Our views and the events, conditions and circumstances on which these future forward-looking statements are based, may change. | ||
| Auditor Name | Mayer Hoffman McCann P.C. | ||
| Auditor Firm ID | 199 | ||
| Auditor Location | San Diego, California |